Juyong Lee, MD
Interventional Cardiology · Farmington, CTNPI 1427216860
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,146 of the $12,677 with a category attached, or 64.3%. 11 manufacturers reported payments, led by Penumbra, Inc. at 50.8% of the total.
Across 65 payments — averaging $195.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$6K
- Abbott$2K
- Boston Scientific$2K
- Philips North America LLC$1K
- W. L. Gore & Associates, Inc.$887
- Medtronic$574
- plus $115 from 5 others
What the payments were for
- Consulting fees$9007%
- Travel & lodging$8,14664%
- Food & beverage$3,60628%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 15 | $6,436 |
| Abbott | 14 | $1,907 |
| Boston Scientific | 14 | $1,675 |
| Philips North America LLC | 2 | $1,083 |
| W. L. Gore & Associates, Inc. | 7 | $887 |
| Medtronic | 7 | $574 |
| Inari Medical, Inc. | 2 | $33 |
| Edwards Lifesciences | 1 | $25 |
| Lantheus Medical Imaging, Inc. | 1 | $21 |
| Bayer | 1 | $19 |
| Novo Nordisk | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$6,283
- CVX-300$1,083
- XIENCE SKYPOINT$1,078
- ANGIOJET$1,050
- CARDIOFORM Septal Occluder$754
- SYMPLICITY G3$429
- OPTIS$367
- ELUVIA$357
How this compares
$12,677 in reported general payments places this provider in the 75th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $75,730 |
| XareltoRivaroxaban | 48 | $42,041 |
| EntrestoSacubitril/Valsartan | 22 | $34,878 |
| LipitorAtorvastatin Calcium | 12 | $6,669 |
| Metoprolol Succinate | 106 | $1,135 |
| Atorvastatin Calcium | 144 | $992 |
| Ezetimibe | 24 | $985 |
| Rosuvastatin Calcium | 39 | $744 |
| ClopidogrelClopidogrel Bisulfate | 117 | $697 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 35 | $565 |
| Amlodipine Besylate | 57 | $361 |
| Cilostazol | 11 | $326 |
| Furosemide | 52 | $283 |
| Losartan Potassium | 33 | $253 |
| Torsemide | 13 | $195 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Farmington
- Khagendra DahalFarmington$42K
- Rohan NaikFarmington$3K
- Michael AzrinFarmington$1K
- Amit VoraNew Haven$409K
- Craig ThompsonHartford$222K
- Michael NannaNew Haven$60K
- Jawad HaiderBloomfield$44K
- Sameer NagpalNew Haven$43K
- Abdul QaziHartford$38K
- Sarfaraz MemonHartford$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.